286 related articles for article (PubMed ID: 32418903)
1. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
[TBL] [Abstract][Full Text] [Related]
2. Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis:
Puri V; Chaudhary KR; Singh A; Singh C
Curr Res Pharmacol Drug Discov; 2022; 3():100084. PubMed ID: 35112077
[TBL] [Abstract][Full Text] [Related]
3. Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.
Sharma A; Vaghasiya K; Ray E; Gupta P; Kumar Singh A; Datta Gupta U; Kumar Verma R
Int J Pharm; 2019 Mar; 558():231-241. PubMed ID: 30630076
[TBL] [Abstract][Full Text] [Related]
4. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.
Suarez S; O'Hara P; Kazantseva M; Newcomer CE; Hopfer R; McMurray DN; Hickey AJ
Pharm Res; 2001 Sep; 18(9):1315-9. PubMed ID: 11683246
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.
Schneider CS; Xu Q; Boylan NJ; Chisholm J; Tang BC; Schuster BS; Henning A; Ensign LM; Lee E; Adstamongkonkul P; Simons BW; Wang SS; Gong X; Yu T; Boyle MP; Suk JS; Hanes J
Sci Adv; 2017 Apr; 3(4):e1601556. PubMed ID: 28435870
[TBL] [Abstract][Full Text] [Related]
6. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
[TBL] [Abstract][Full Text] [Related]
7. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
[TBL] [Abstract][Full Text] [Related]
8. Reclaiming hijacked phagosomes: Hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells.
Sharma A; Vaghasiya K; Gupta P; Gupta UD; Verma RK
Int J Pharm; 2018 Jan; 536(1):50-62. PubMed ID: 29180254
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
Almutairi M; Hefnawy A; Almotairy A; Alobaida A; Alyahya M; Althobaiti A; Adel Ali Youssef A; Elkanayati RM; Ashour EA; Smyth HDC; Repka MA
Int J Pharm; 2024 Apr; 655():124044. PubMed ID: 38527563
[TBL] [Abstract][Full Text] [Related]
10. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
[TBL] [Abstract][Full Text] [Related]
11. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
12. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
[TBL] [Abstract][Full Text] [Related]
14. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
Sharma R; Saxena D; Dwivedi AK; Misra A
Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
[TBL] [Abstract][Full Text] [Related]
15. Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis.
Marcianes P; Negro S; Barcia E; Montejo C; Fernández-Carballido A
AAPS PharmSciTech; 2019 Dec; 21(1):15. PubMed ID: 31807908
[TBL] [Abstract][Full Text] [Related]
16. Inhalation Delivery of Host Defense Peptides (HDP) using Nano- Formulation Strategies: A Pragmatic Approach for Therapy of Pulmonary Ailments.
Adlakha S; Sharma A; Vaghasiya K; Ray E; Verma RK
Curr Protein Pept Sci; 2020; 21(4):369-378. PubMed ID: 31889487
[TBL] [Abstract][Full Text] [Related]
17. Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles.
Popov A; Schopf L; Bourassa J; Chen H
Int J Pharm; 2016 Apr; 502(1-2):188-97. PubMed ID: 26902722
[TBL] [Abstract][Full Text] [Related]
18. Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery.
Miranda MS; Rodrigues MT; Domingues RMA; Torrado E; Reis RL; Pedrosa J; Gomes ME
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():1090-1103. PubMed ID: 30274040
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.
Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A
Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002
[TBL] [Abstract][Full Text] [Related]
20. Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation.
Jadhav K; Jhilta A; Singh R; Ray E; Sharma N; Shukla R; Singh AK; Verma RK
Biomater Adv; 2023 Nov; 154():213594. PubMed ID: 37657277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
